Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia

Correction to: Clinical and Experimental Nephrology https://doi.org/10.1007/s10157-019-01811-9

In the original publication of the article the presentation of Table 1 was incorrectly published. The corrected table (Table 1) is given below.

The original article has been corrected.

Table 1 Clinical trials of dotinurad